Targeting inflammation to slow or delay functional decline: where are we?
Authors: Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S, Lattanzio F
Date: 2010
Scope of interest: biogerontology
06 99 39
Recup number
You may also be interested in:
A case of metachronousperipheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin diseasesuccessfullytreated with Brentuximab Vedotin
Authors: Meconi F,Provenzano I, Nasso D, Mariotti B, Pupo L, Secchi R, Cerretti R, Lucia A, Arcese W, Cantonetti M
Date: 2020
Scope of interest: Haematology
Read details
Intravenous administration of Rituximab in the treatment of Primary Cutaneous B-Cell Lymphomas (PCBCLs): a retrospective study
Authors:
Date: 2014
Scope of interest: Haematology
Read details
Several impact of inflammatory markers on insulin resistance in the elderly.
Authors: Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafè M, Barbieri M, Corsi AM, Lauretani F, Franceschi C and Paolisso G
Date: 2004
Scope of interest: ageing, geriatrics
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
